StockData
Oscar Health, Inc. logo

Oscar Health, Inc. (OSCR) stock

OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3028% above fair value
$31.33+0.28 (+0.90%)

Close on Nov 16, 2026Market cap $9.67BP/E 22.4Yield –

How the market prices Oscar Health

Each ratio against its own distribution since 2021, from month-end prices and the figures reported at the time

Oscar Health trades at 0.6× its earnings, against a median of 0.5× since 2021 — on the expensive side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2021, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2021

Median 0.5×, today 0.6×

What Oscar Health keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Operating margin4.11%vs 4.11%
EBITDA margin4.30%vs 13.5%
Pretax margin3.85%vs 13.7%
Net margin3.60%vs 11.0%
Free cash flow margin28.6%vs 17.7%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity34.3%vs 13.8%
Return on assets6.25%vs 2.98%
Return on capital employed24.8%vs 5.37%

How hard the assets work

Revenue per dollar of assets1.74vs 0.26
Revenue per employee$6.65Mvs $1.75M
Profit per employee$238.93Kvs $210.82K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $8.12B. That is 524.2% of the $1.55B it would cost to buy the business outright.

Total debt$431.63M
Cash and short-term investments$8.56B
EBITDA, trailing twelve months$657.96M
Free cash flow, trailing twelve months$4.38B

Leverage and liquidity

Debt to equity0.21vs 0.31
Debt to EBITDA0.66vs 2.51
Net debt to EBITDA-12.35vs -0.51
Debt to free cash flow0.10vs 2.75
Current ratio1.08vs 1.47
Quick ratio1.03vs 0.98

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

1.97
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

4 of 9 tests passed

Price against two rules of thumb

Graham's number and Lynch's fair value, both derived from current earnings.

Graham $14.47Price $31.33

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield5.70%vs 9.24%
Free cash flow yield45.3%vs 11.0%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 16, 2026

$10.6952-week low52-week high$38.50
200-day$31.3350-day20-day

The close sits 74% of the way up the 52-week range, 18.6% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

47
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

OSCRS&P 500
PeriodOSCRS&P 500DifferenceOSCR per yearS&P 500 per year
1 month-1.8%-3.1%+1.3 pts
3 months-4.4%-4.5%+0.1 pts
Year to date+118.0%+9.4%+108.7 pts
1 year+125.7%+11.3%+114.4 pts
3 years+338.2%+70.4%+267.8 pts+63.6%+19.4%
5 years+162.6%+68.6%+94.0 pts+21.3%+11.0%
10 years+313200.0%+297.7%+312902.3 pts+123.7%+14.8%

How much it moves

Volatility, 1 year65.4%vs 28.2%
Volume against its 90-day average1.08vs 0.89

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

17M OSCR shares were sold short on Oct 30, 2026, down 8.5% from the previous report, or 6.85% of the shares available to trade. At recent volumes it would take 3.9 days to buy them back. Over the last 20 sessions, 42.9% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float6.85%vs 3.81%
Short interest as a share of all shares5.42%vs 3.02%
Days of volume to buy it back3.92vs 4.05

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202616,733,424-8.5%4,272,9013.9
Oct 15, 202618,294,074+11.2%4,904,5783.7
Sep 30, 202616,451,694-7.4%6,135,5802.7
Sep 15, 202617,770,151+8.6%4,867,2613.6
Aug 31, 202616,364,378-0.5%4,710,5433.5
Aug 14, 202616,438,924-7.8%7,036,7972.3
Jul 31, 202617,825,961-8.9%4,364,3864.1
Jul 15, 202619,577,008+4.4%4,887,1154.0
Jun 30, 202618,743,478+7.3%6,840,3112.7
Jun 15, 202617,466,177-2.9%8,609,1752.0
May 29, 202617,993,392-2.1%7,009,0142.6
May 15, 202618,386,402-24.7%10,125,2151.8

Every measure, in full

92 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 9, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 16, 2026

Valuation ratiosIndustry

Market Cap
$9.67B
$3.44B
Enterprise Value
$1.55B
$2.85B
PE Ratio
22.38
10.62
PS Ratio
0.63
1.16
PB Ratio
4.71
1.58
P/TBV Ratio
4.71
1.78
P/FCF Ratio
2.21
8.55
P/OCF Ratio
2.19
7.57

Enterprise valuationIndustry

EV / Sales
0.10
0.96
EV / EBITDA
2.35
6.47
EV / EBIT
2.46
9.44
EV / FCF
0.35
7.23

Share statisticsIndustry

Shares Change (YoY)
25.1%
-1.29%
Float
244M
57M
Shares Held by Insiders
20.9%
3.33%
Shares Held by Institutions
64.7%
84.6%

Short sellingIndustry

Short Interest
17M
–
Short Interest Change
-8.53%
-2.56%
Short % of Float
6.85%
3.81%
Short % of Shares Outstanding
5.42%
3.02%
Days to Cover
3.92
4.05

Stock price statisticsIndustry

52-Week High
$38.50
–
52-Week Low
$10.69
–
20-Day Moving Average
$32.00
–
50-Day Moving Average
$31.98
–
200-Day Moving Average
$24.52
–
Average True Range (14)
$2.08
–
Price Change (1 Week)
-2.52%
1.73%
Price Change (1 Month)
-1.76%
3.84%
Price Change (3 Months)
0.16%
2.02%
Price Change (6 Months)
23.8%
9.29%
Price Change (YTD)
118.0%
9.06%
Price Change (1 Year)
124.6%
10.8%
Price Change (3 Years)
311.7%
44.2%
Price Change (5 Years)
168.0%
45.3%
Average Volume (10 Days)
7M
–
Average Volume (20 Days)
6M
–
Average Volume (90 Days)
5M
–
Relative Volume
1.08
0.89
Relative Strength Index (14)
47.4
56.8
Volatility (1 Year)
65.4%
28.2%

MarginsIndustry

Pretax Margin
3.85%
13.7%
Profit Margin
3.60%
11.0%
EBITDA Margin
4.30%
13.5%
FCF Margin
28.6%
17.7%

Returns on capitalIndustry

Return on Equity (ROE)
34.3%
13.8%
Return on Assets (ROA)
6.25%
2.98%
Return on Capital Employed (ROCE)
24.8%
5.37%

Financial positionIndustry

Current Ratio
1.08
1.47
Quick Ratio
1.03
0.98
Debt / Equity
0.21
0.31
Debt / EBITDA
0.66
2.51
Debt / FCF
0.10
2.75
Net Debt / EBITDA
-12.35
-0.51
Interest Coverage
39.73
4.71

GrowthIndustry

Revenue Growth (YoY)
42.8%
7.21%
FCF Growth (YoY)
264.5%
8.96%
Revenue Growth (3Y CAGR)
43.5%
9.53%
Revenue Growth (5Y CAGR)
90.8%
8.29%

EfficiencyIndustry

Asset Turnover
1.74
0.26
Revenue Per Employee
$6.65M
$1.75M
Profits Per Employee
$238.93K
$210.82K
Employee Count
2,305
1,341

Income statement (TTM)Industry

Revenue
$15.32B
$4.57B
Operating Income
$629.72M
$623.46M
Pretax Income
$589.81M
$621.07M
Net Income
$550.74M
$518.06M
EBITDA
$657.96M
$729.00M
EPS (Diluted)
$1.40
$4.92

Balance sheetIndustry

Total Debt
$431.63M
$668.00M
Net Cash (Debt)
$8.12B
$327.69M
Net Cash Per Share
$26.32
$5.27
Equity (Book Value)
$2.05B
$3.44B
Book Value Per Share
$6.65
$39.45
Tangible Book Value
$2.05B
$2.59B
Working Capital
$683.68M
$489.26M

Cash flow (TTM)Industry

Operating Cash Flow
$4.42B
$698.90M
Capital Expenditures
-$38.63M
-$11.90M
Free Cash Flow
$4.38B
$580.82M
FCF Per Share
$14.19
$8.49

Dividends and yieldsIndustry

Earnings Yield
5.70%
9.24%
FCF Yield
45.3%
11.0%

Taxes and interestIndustry

Interest Expense
$15.85M
$76.64M
Income Tax
$38.88M
$103.95M
Effective Tax Rate
6.59%
19.6%

Scores and fair valueIndustry

Graham Number
$14.47
$78.02
Graham Upside
-53.8%
13.4%
Altman Z-Score
1.97
0.90
Piotroski F-Score
4
5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?